GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NFL Biosciences SA (XPAR:ALNFL) » Definitions » Notes Receivable

NFL Biosciences (XPAR:ALNFL) Notes Receivable : €0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is NFL Biosciences Notes Receivable?

NFL Biosciences's Notes Receivable for the quarter that ended in Dec. 2024 was €0.00 Mil.


NFL Biosciences Notes Receivable Historical Data

The historical data trend for NFL Biosciences's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NFL Biosciences Notes Receivable Chart

NFL Biosciences Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Notes Receivable
Get a 7-Day Free Trial - - - - -

NFL Biosciences Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

NFL Biosciences Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


NFL Biosciences Notes Receivable Related Terms

Thank you for viewing the detailed overview of NFL Biosciences's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


NFL Biosciences Business Description

Traded in Other Exchanges
Address
199 rue Helene Boucher, Castelnau-le-Lez, FRA, 34170
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

NFL Biosciences Headlines

No Headlines